Response to erythropoietin and moxifloxacin in a patient with myelodysplastic syndrome non-respondent to erythropoietin alone.
We describe a low-risk myelodysplastic syndrome patient who did not respond to erythropoietin alone, but who did show a major erythroid response to combination therapy consisting of erythropoietin and moxifloxacin. This observation was exclusively empirical. The immunomodulatory effects of moxifloxacin may explain the synergy with erythropoietin.
Fragasso
Alberto
A
Unità Operativa di Medicina Interna, Presidio Ospedaliero di Matera, ASL N degrees 4, via Lanera, 75100, Matera, Italy
Mannarella
Clara
C
Sacco
Andrea
A